Tag: Blood
Fiasp® Demonstrated Effective Overall Blood Sugar Reductions in People With Advanced Type 2 Diabetes Uncontrolled on Multiple Daily Injections (B

Fiasp® Demonstrated Effective Overall Blood Sugar Reductions in People With Advanced Type 2 Diabetes Uncontrolled on Multiple Daily Injections (B

BAGSVÆRD, Denmark, Sept. 17, 2019 /PRNewswire/ -- New data presented today at the 55(th) Annual Meeting of the European Association for the Study of Diabetes (EASD) showed ...

Lees verder
Advances In The Global Search For Blood Markers For Alzheimer's Disease And Other Dementias

Advances In The Global Search For Blood Markers For Alzheimer's Disease And Other Dementias

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2019 LOS ANGELES, July 15, 2019 /PRNewswire/ -- Significant advances in the global search for blood test technologies ...

Lees verder
OneTouch® Blood Glucose Monitoring System Accuracy Proven in New Long-Term Study

OneTouch® Blood Glucose Monitoring System Accuracy Proven in New Long-Term Study

Research demonstrates clinical accuracy of OneTouch Select Plus® platform, and demonstrates the value of a continuous and systematic testing program to verify product ...

Lees verder
Study Shows Intensive Blood Pressure Control Reduces Risk Of Mild Cognitive Impairment (MCI) And The Combined Risk Of MCI And Dementia

Study Shows Intensive Blood Pressure Control Reduces Risk Of Mild Cognitive Impairment (MCI) And The Combined Risk Of MCI And Dementia

Plus: - Genomic Analysis of Alzheimer's Study May Enable a Precision Medicine Approach CHICAGO, July 25, 2018 /PRNewswire/ -- Significant reductions in the risk of mild ...

Lees verder
AAIC® 2018 Features First Clinical Trial to Show Intensive Blood Pressure Treatment Reduces New Cases of Mild Cognitive Impairment and Dementia (

AAIC® 2018 Features First Clinical Trial to Show Intensive Blood Pressure Treatment Reduces New Cases of Mild Cognitive Impairment and Dementia (

CONFERENCE ALSO RELEASES FIRST-EVER DEMENTIA DATA IN LGB SENIORS, AND WOMEN'S DEMENTIA RISK RELATED TO REPRODUCTIVE HISTORY CHICAGO, July 25, 2018 /PRNewswire/ -- The first ...

Lees verder
Significant Blood Sugar Improvement With Xultophy® Compared to Insulin Glargine U-100 When Used as Add-On to Oral Diabetes Medications

Significant Blood Sugar Improvement With Xultophy® Compared to Insulin Glargine U-100 When Used as Add-On to Oral Diabetes Medications

BAGSVÆRD, Denmark, June 23, 2018 /PRNewswire/ -- Oral Presentation #127-OR Adults with type 2 diabetes treated with Xultophy(R) (insulin degludec and liraglutide injection) ...

Lees verder
Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial

Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial

ORLANDO, Florida, June 23, 2018 /PRNewswire/ -- Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood ...

Lees verder
Tresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evid

Tresiba® Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evid

ORLANDO, Florida, June 23, 2018 /PRNewswire/ -- Adults with type 2 diabetes treated with Tresiba(R) (insulin degludec injection) had a significant reduction in HbA1c and a 30% ...

Lees verder
Pivotal Study Reveals Effectiveness of Blood Tests in Screening for Sleep Apnea in Adult Males

Pivotal Study Reveals Effectiveness of Blood Tests in Screening for Sleep Apnea in Adult Males

Published findings show initial testing for three specific biomarkers may provide superior results over standard screening methods BREA, California, June 19, 2018 /PRNewswire/ ...

Lees verder
Ryzodeg® Significantly Reduces the Risk of Low Blood Sugar in People With Type 2 Diabetes who Fast During Ramadan

Ryzodeg® Significantly Reduces the Risk of Low Blood Sugar in People With Type 2 Diabetes who Fast During Ramadan

ABU DHABI, UAE, December 7, 2017 /PRNewswire/ -- In people with type 2 diabetes who fast during Ramadan, Ryzodeg(R) (insulin degludec/insulin aspart) reduced the overall rate ...

Lees verder
BizPress.nl